Rare urogenital diseases

Thematic Session 18

  • Location:
    Room Vienna (Hall B2, level 0)
  • Chair:
     T.S. O'Brien, London (GB)
  • Aims and objectives of this session

    Had too much PSA, MRI, OAB, BPH, robots…?

    Then come and find out about something really new at EAU 2016!

    The EU, national governments across Europe, and the EAU are making the investigation and treatment of rare diseases an organisational priority. Come to this session to find out from leading policy makers and clinicians how you and your department can be part of this work. Rare diseases are common in urology.

State-of-the-art lecture European Reference Networks (ERNs) on rare or low prevalence and complex diseases

To be confirmed

State-of-the-art lecture EAU development of a European Reference Network (ERN) on rare and complex urogenital diseases and conditions
 M. Battye, Sheffield (GB)
State-of-the-art lecture Centralised treatment of testis cancer
 A. Lorch, Düsseldorf (DE)
Aims and objectives of this presentation

This session will highlight and discuss the pro and cons of centralised treatment of germ cell cancer patients focussing on chemotherapy treatment and residual tumour resection in advanced and relapsed patients.

State-of-the-art lecture Paediatric urology rare congenital diseases
 W.F.J. Feitz, Nijmegen (NL)
Aims and objectives of this presentation

Paediatric urology is taking care of congenital and requered diseases of the urogenital tract. Recently national expert centers have been recognised on their expertise for different urological diseases. This is based on the multidisciplinary teams, the research involved and recognition by patient societies. An overview of current European developments will be presented within the field of paediatric urology, development of life long care tools, training tools and patient involvement.

State-of-the-art lecture Complex rare treatments
 W. Artibani, Verona (IT)